Content about Archimedes Pharma

January 23, 2012
ReportersNotebook — Chain Pharmacy, 1/30/12

The Food and Drug Administration is streamlining the enrollment process for risk evaluation and mitigation strategies for a class of painkillers, the agency said.

SUPPLIER NEWS — The Food and Drug Administration is streamlining the enrollment process for risk evaluation and mitigation strategies for a class of painkillers, the agency said. The FDA announced the approval of a single REMS for transmucosal immediate-release fentanyl drugs. The new system, which takes effect in March, will allow prescribers and pharmacies to enroll into one system instead of individual systems for each product.

October 17, 2011
Archimedes Pharma launches Lazanda for breakthrough cancer pain

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

BEDMINSTER, N.J. — Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

Archimedes announced the launch of Lazanda (fentanyl) nasal spray for adult patients who have developed a tolerance to opioid therapy for persistent, underlying cancer pain. The drug uses Archimedes' patented PecSys delivery system, which allows the drug to be absorbed across the nasal membrane and directly into the bloodstream. The Food and Drug Administration approved the drug on June 30.

July 5, 2011
Lazanda approved as breakthrough pain treatment

The Food and Drug Administration has approved a drug made by Archimedes Pharma for treating breakthrough pain in cancer patients, Archimedes said last week.

BEDMINSTER, N.J. — The Food and Drug Administration has approved a drug made by Archimedes Pharma for treating breakthrough pain in cancer patients, Archimedes said last week.

Archimedes announced the approval of Lazanda (fentanyl) nasal spray for cancer patients who have acquired a tolerance to opioid drugs. Breakthrough pain is an intense, sudden pain that is unpredictable and often debilitating and occurs despite otherwise appropriate pain therapy.

August 22, 2010
British drug maker to open U.S. headquarters in N.J.

British drug maker Archimedes Pharma plans to set up its U.S. headquarters in New Jersey,...